BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Melanoma Institute Australia - ECPv6.16.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://melanoma.org.au
X-WR-CALDESC:Events for Melanoma Institute Australia
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Australia/Sydney
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250405T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20251004T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20260404T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20261003T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20270403T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20271002T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260703T170000
DTEND;TZID=Australia/Sydney:20260703T170000
DTSTAMP:20260616T032052
CREATED:20260602T044844Z
LAST-MODIFIED:20260602T044906Z
UID:10000305-1783098000-1783098000@melanoma.org.au
SUMMARY:SHP Pilot Grants
DESCRIPTION:SHP Pilot Grants – Funding to Test and Implement Research Into Clinical Practice \nEach year\, Sydney Health Partners funds pilot projects that help clinicians\, researchers and health professionals turn evidence into practical healthcare solutions and scale up the implementation of research for broader impact. \nIf you’re a health professional\, clinician\, or researcher leading research within Sydney Health Partners’ affiliated health services\, a Pilot Grant could help you to: \n\nTest real-world implementation of research innovations\nSolve complex health system challenges with practical solutions\nStrengthen applications for major funding bodies (NHMRC\, MRFF\, TRGS)\n\nApplications are now open for Sydney Health Partners 2026 Implementation Science Pilot Grants. \nSydney Health Partners are offering up to $220\,000 in grants to support up to 11 pilot projects\, with two of the projects to be funded by the Charles Perkins Centre Implementation Hub through the Jennie Mackenzie Research Fund. \nGrant Categories: \nStream 1: SHP Implementation Science Pilot Grants (up to 9) \nThese grants require two Principal Investigators (PIs):   \n\nOne from the University of Sydney or an SHP Partner Medical Research Institute (MRI)\n\n\nOne from an SHP Health Service Partner\n\nStream 2: CPC Implementation Hub Pilot Grants (x2) \nThese grants require two PIs – One must be a member of the Charles Perkins Centre: \n\nOne must be a University of Sydney or SHP Partner MRI employee\n\n\nOne from an SHP Health Service Partner\n\n\nKey Dates:\nApplications close: 3 July 2026\, 5:00pm AEST\nSuccessful applicants will be notified: August 2026\nGrants will commence: from January 2027 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/shp-pilot-grants/
CATEGORIES:Grants,Discovery
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/06/SHP-Pilot-Grants-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260707T170000
DTEND;TZID=Australia/Sydney:20260707T170000
DTSTAMP:20260616T032052
CREATED:20260505T055547Z
LAST-MODIFIED:20260505T055547Z
UID:10000290-1783443600-1783443600@melanoma.org.au
SUMMARY:RACP Research Awards and Career Grants
DESCRIPTION:Through the RACP Foundation\, we’re able to offer financial support to Fellows and trainees pursuing careers in medical research. Over 50 different fellowships\, scholarships and grants are available annually\, totalling over $2.5 million in funding. \nCareer Development Fellowships are intended for mid-career researchers who completed their research higher degree over 7 years ago and/or researchers who are not eligible for either Research Entry Scholarship or Research Establishment Fellowships. \nResearch Establishment Fellowships are available to Fellows and Advanced Trainees who want to establish themselves in a research career. \nResearch Entry Scholarships provide stipend support only and are to assist Fellows and Advanced Trainees who are: \n\nat the start of their research careers and about to enrol in a Masters\, PhD or equivalent research higher degree\nin the 1st or 2nd full-time equivalent year of their research degree.\n\n\nKey Dates\nApplications close: 30 June 2026\nApplications close (Research Entry Scholarships): 7 July 2026\nOutcomes advised: December 2026 \nSEE WEBSITE
URL:https://melanoma.org.au/event/racp-awards-grants/
CATEGORIES:Grants,Early to Mid Career Researcher
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/05/RACP-Awards-and-Grants-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260714T170000
DTEND;TZID=Australia/Sydney:20260714T170000
DTSTAMP:20260616T032052
CREATED:20260505T055930Z
LAST-MODIFIED:20260505T055930Z
UID:10000291-1784048400-1784048400@melanoma.org.au
SUMMARY:MRFF National Critical Research Infrastructure
DESCRIPTION:The 2026 National Critical Research Infrastructure initiative invests in research infrastructure to ensure Australian researchers find innovative solutions to complex health problems in areas of unmet medical need. This grant opportunity has four streams. \nStream 1 – Innovation enablers\nAddress an area of unmet medical need by promoting the development and implementation of new research infrastructure by supporting development and/or expansion of research enablers such as biobanks\, tissue repositories\, novel platforms\, and secure health data environments to create valuable research resources. \nStream 2 – Digitisation of health care\nTranslate or implement innovative artificial intelligence technologies into health applications that: \n\nbenefit multiple health disciplines/areas\ninvolve consumers in the research journey to ensure the research is applicable to the needs of the Australian community; and\nincrease artificial intelligence workforce capacity and capability\, particularly in relation to health\, through cross-sector and interdisciplinary collaboration.\n\nStream 3 – Co-investment partnerships\nUtilise co-investment (cash only) with the research sector\, state and/or territory governments\, and industry\, in significant critical research infrastructure (e.g. facilities\, personnel and equipment): \n\nto support development of research capacity\, capability and/or effectiveness in an area of unmet medical need\, or\nto enable Australian research using new platforms\, systems and services in an area of unmet medical need.\n\nStream 4 – mRNA technology enablers\nLeverage and enhance emerging mRNA technologies\, platforms\, and/or equipment to accelerate development of mRNA-based vaccines and therapeutics in an area of unmet medical need. \nGrants to fund research infrastructure projects\, up to $3 million in Streams 1\, 2 and 4\, and up to $7 million in Stream 3. \nAn application may only be submitted to one of the above four streams. Applicants must specify the stream to which they are applying in their application. \n\n\n\nKey Dates\nApplications close: 14 July 2026\nIndicative funding status: Funding anticipated to be awarded from December 2026 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/mrff-research-infrastructure/
CATEGORIES:Grants,Infrastructure & Equipment
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/05/MRFF_Critical-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260722T170000
DTEND;TZID=Australia/Sydney:20260722T170000
DTSTAMP:20260616T032052
CREATED:20260505T060230Z
LAST-MODIFIED:20260505T060230Z
UID:10000292-1784739600-1784739600@melanoma.org.au
SUMMARY:MRFF BioMedTech Incubator
DESCRIPTION:The MRFF 2026 BioMedTech Incubator Program provides grants of financial assistance to support medical research and medical innovation projects through the establishment of BioMedTech Incubators. \nThis grant is for an eligible organisation who can establish a working incubator\, to partner with Australian small and medium enterprises (SMEs) to progress new and innovative medical research projects through the early stages of development. \nThe 2026 BioMedTech Grant Opportunity is part of the Medical Research Future Fund under the Medical Research Commercialisation Initiative. \nThis opportunity looks to fund suitable organisations to identify\, select and support Australian SMEs undertaking early-stage medical research and medical innovation projects that have commercial potential. \nThe intended outcome of the research funded by this grant opportunity is to improve the health and wellbeing of Australians by increasing the number of SMEs developing novel biomarkers\, diagnostics\, therapeutics\, assistive devices and/or digital technologies that have progressed through the early stages of research and development to the point where they are ‘de-risked’ and attractive to private investment for commercialisation. \nApplicants may propose to support development of innovations in their area/s of strength (i.e. applicants are not required to propose a program that covers the breadth of the biomedtech sector). \nGrants of up to $33 million to establish BioMedTech Incubators. \n\nKey Dates\nApplications close: 22 July 2026\nIndicative funding status: Funding anticipated to be awarded from December 2026 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/mrff-incubator/
CATEGORIES:Grants,Industry
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/05/MRFF_Incubator-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260729T170000
DTEND;TZID=Australia/Sydney:20260729T170000
DTSTAMP:20260616T032052
CREATED:20260602T051412Z
LAST-MODIFIED:20260603T013901Z
UID:10000299-1785344400-1785344400@melanoma.org.au
SUMMARY:NHMRC Investigator Grants
DESCRIPTION:Investigator Grants provide the highest-performing researchers at all career stages with consolidated funding for their salary (if required) and a significant research support package. \nIn this way\, the Chief Investigator has flexibility to pursue important new research directions as they arise\, adjust their resources accordingly\, and to form collaborations as needed\, rather than being restricted to the scope of a specific research project. \nInvestigator Grants support: \n\nResearch across the 4 pillars of health and medical research: biomedical\, clinical\, public health and health services research.\nAll career stages: early career researchers\, mid-career researchers and established researchers\nResearchers with clinical responsibilities (such as clinicians\, public health and allied health practitioners)\nFull-time and part-time researchers.\n\nInvestigator Grants aim to: \n\nAllow flexibility for investigators to pursue important new research directions as they arise and to form collaborations as needed\nFoster innovative and creative research\nCreate opportunities for researchers at all career stages to establish their own research programs\nReduce application and peer review burden on researchers.\n\n\nKey Dates:\nApplications open: 3 June 2026\nMinimum data due: 1 July 2026\nApplications close: 29 July 2026\nProposed peer review: August – November 2026\nOutcomes to be advised: March 2027 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/nhmrc-investigator-grants/
CATEGORIES:Grants,Early to Mid Career Researcher
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/05/NHMRC-Investigator-Grants-600-x-338-px.jpg
END:VEVENT
END:VCALENDAR